Hassanein Waleed H 4
4 · TransMedics Group, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Hassanein Waleed H
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2024-09-16$13.28/sh+8,625$114,540→ 70,268 total - Sale
Common Stock
2024-09-16$151.10/sh−908$137,199→ 69,360 total - Sale
Common Stock
2024-09-16$155.65/sh−688$107,087→ 62,269 total - Sale
Common Stock
2024-09-16$153.32/sh−3,155$483,725→ 64,340 total - Sale
Common Stock
2024-09-16$152.30/sh−1,865$284,040→ 67,495 total - Sale
Common Stock
2024-09-16$154.16/sh−1,383$213,203→ 62,957 total - Sale
Common Stock
2024-09-16$156.48/sh−626$97,956→ 61,643 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-16−8,625→ 104,875 totalExercise: $13.28Exp: 2032-02-22→ Common Stock (8,625 underlying)
Holdings
- 469,359(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on September 6, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $150.64 to $151.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $151.83 to $152.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $152.88 to $153.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $153.92 to $154.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F6]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $155.15 to $156.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F7]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $156.19 to $157.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F8]The option is fully vested.